Key facts
- It has raised $29.3M; the latest was PE Growth/Expansion ($28.0M) in Sep 2025.
- Notable investors include 5 Horizons Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for LPOXY Therapeutics
- ·The full record, as it builds
Funding rounds
No funding rounds for LPOXY Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About LPOXY Therapeutics
Developer of orally administered intestinal oxygen delivery therapy intended to prevent antibiotic-induced superinfections. The company offers capsules that deliver oxygen directly to the bowel, enabling patients to develop targeted therapies.
- Sector
- Healthcare
- HQ
- Platte City, MO, United States
- Founded
- 2020
- Website
- lpoxy.com/
- Ownership
- Privately Held (backing)
LPOXY Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LPOXY Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LPOXY Therapeutics in its N-PORT filings yet. We sweep new filings monthly.